abstract |
The present invention relates to a stem cell composition for intravenous administration, which has a diameter of 10 to 20 탆 and contains stem cells presenting as single cells at 1 × 10 7 to 5 × 10 8 cells / ml. INDUSTRIAL APPLICABILITY According to the present invention, it is possible to provide a stem cell composition suitable for intravenous administration, and it is possible to more efficiently increase the efficacy of stromal cells injected into a blood vessel by stably reaching a target tissue and thus to exhibit activity, Can be dramatically improved. |